Figure 5

Moderate to no alteration in inflammatory markers in conjunction with diet and treatment. TNF-alpha cerebellar levels (top) in both males and females. n = 5 (SAL/n-3 bal male), 5 (VPA/n-3 bal male), 4 (SAL/n-3 supp male), 4 (VPA/n-3 supp male), 4 (SAL/n-3 bal female), 5 (VPA/n-3 bal female), 5 (SAL/n-3 supp female) and 5 (VPA/n-3 supp female) mice. TGF-beta cerebellar levels (middle) in both males and females. n = 5 (SAL/n-3 bal male), 5 (VPA/n-3 bal male), 5 (SAL/n-3 supp male), 4 (VPA/n-3 supp male), 5 (SAL/n-3 bal female), 5 (VPA/n-3 bal female), 5 (SAL/n-3 supp female), 4 (VPA/n-3 supp female) mice. ARG cerebellar levels (bottom) in both males and females. n = 5 (SAL/n-3 bal male), 5 (VPA/n-3 bal male), 5 (SAL/n-3 supp male), 4 (VPA/n-3 supp male), 5 (SAL/n-3 bal female), 5 (VPA/n-3 bal female), 5 (SAL/n-3 supp female), 4 (VPA/n-3 supp female) mice. Data are expressed as median and min to max and were analyzed through a two-way ANOVA followed by Tukey post-hoc multiple analysis. *p < 0.05, **p < 0.01, ***p < 0.001.